MUSC’s pipeline programs build the skills of underrepresented students and prepare them for careers in health care and medical research.

A recent MUSC study found that hypertensive disorders of pregnancy may contribute to higher rates of blood clots in women years after delivery.

For people with HIV, the risk of anal cancer varies significantly depending on the region of the country where they live.

MUSC’s ReJoyce Green, Ph.D., leads study highlighted in prestigious publication showing which factors may predict substance use in adolescents.

After melanoma surgery, hairdresser Carol Helton is spreading the word at her hair salon about staying on top of suspicious moles.

A clinical trial of CAR-T cell therapy developed at Hollings has received NCI funding to expand.

An Ewing sarcoma researcher at MUSC is one of three scientists nationwide to receive a career development award from the Rally Foundation.

Teams working to improve substance use screening in trauma centers and relieve symptoms of a connective tissue disease take home this year’s Blue Sky Awards.

The Department of Psychiatry and Behavioral Sciences ranked ninth in the country for NIH funding in 2023.

Hollings researchers use patented technology to improve immunotherapy by prolonging survival of cancer-fighting T-cells.